July 9, 2007 - Medtronic Inc. announced the commercial launch of its latest cardiac resynchronization therapy-defibrillator, the Concerto CRT-D, and its latest implantable cardioverter-defibrillator, the Virtuoso ICD, which are the first of their kind in the Japanese market.
The CRT-D devices are equipped with the functions of an ICD, while also providing cardiac resychronization therapy for patients suffering from heart failure. The Concerto and Virtuoso are the first devices in Japan with wireless functionality, designed to reduce follow-up and procedure times.

July, 6, 2007 – Toshiba America Medical Systems, Inc. announced a partnership with CVCTA Education to provide a Peripheral Vascular CTA (PV-CTA) training course in a move to strengthen its position in medical education and improved patient care.
This course will be the first of its kind to exceed current ACCF/AHA Level 2 requirements in the ACCF/AHA Clinical Competence Statement on Cardiac Imaging with Computed Tomography and Magnetic Resonance.

July 6, 2007 - CardioTech International Inc. announced that it has signed an agreement to sell its Gish Biomedical Inc. subsidiary in a stock transaction to Medos Medizintechnik AG (Medos) for nearly $7.5 million in a move that will allow CardioTech to invest the proceeds in its growth initiatives.

July 5, 2007 - Agfa HealthCare presented its completely integrated CVIS-radiology PACS with full-featured echocardiography image and reporting capabilities at the 18th annual American Society of Echocardiography (ASE) Scientific Sessions in June 2007 in Seattle, WA, USA.

July 5, 2007 – Covidien Ltd., formerly known as Tyco Healthcare, recently spun off from Tyco International, began trading on July 2 at the New York and Bermuda Stock Exchanges, marking its debut as an independent diversified healthcare products company.

July 5, 2007 — Vascular Solutions, Inc. announced that it has received 510(k) clearance from the U.S. Food & Drug Administration to launch the Gopher support catheter in the United States.

The Gopher catheter is designed to assist in the passage of interventional devices through arterial lesions by utilizing a unique rotational force. The Gopher catheter will be available in both 3 French and 2 French sizes and is part of Vascular Solutions' specialty catheter product line.

July 5, 2007 – The FDA has cleared Spectranetics Corp. to market its TURBO-Booster product for the treatment of arterial stenoses and occlusions in the leg, a peripheral laser catheter that functions as a guiding catheter facilitating directed ablation of blockages in the main arteries at or above the knee.

July 3, 2007 - Ivivi Technologies Inc., a non-invasive, electrotherapeutic technology developer, announced that it has completed enrollment of 30 patients participating in a double-blind, randomized, placebo-controlled clinical trial utilizing its pulsed electromagnetic field (PEMF) technology to treat patients with ischemic cardiomyopathies conducted at The Cleveland Clinic Florida.

July 3, 2007 - Vascular Solutions Inc. announced that the FDA has granted 510(k) clearance for the Gopher support catheter, a catheter designed to assist in the passage of interventional devices through arterial lesions by utilizing a rotational force.
The Gopher catheter is designed designed to meet specific needs of physicians performing interventional percutaneous procedures in coronary and peripheral arteries, such as facilitating the passing of an angioplasty balloon in challenging coronary interventions.

July 3, 2007 - CryoCor, Inc. and Boston Scientific Corporation announced on June 28 a strategic collaboration in the field of cryoablation for treating cardiac arrhythmias, in which they will co-develop therapeutic solutions for atrial fibrillation, or Afib.

Subscribe Now